RPG Investment Advisory’s Sagimet Biosciences SGMT Stock Holding History

RPG Investment Advisory’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Buy	+17,350	New	+$118K	0.01%	92

Other funds holding SGMT

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

APG

Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

NFG

Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

RPG Investment Advisory's SGMT Position: Q2 2026 in Review

RPG Investment Advisory opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 17,350 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #92 among its holdings.

17 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

RPG Investment Advisory held 17,350 shares of Sagimet Biosciences worth $134K as of Q2 2026.
Sagimet Biosciences was a new RPG Investment Advisory position in Q2 2026.
Sagimet Biosciences made up 0.01% of RPG Investment Advisory's portfolio in Q2 2026, its #92 holding.
17 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on RPG Investment Advisory's 13F filing for Q2 2026, filed 4 Aug 2026.